Global Transmucosal Drug Delivery Devices Market Research Report 2023

Publisher Name :
Date: 09-Mar-2023
No. of pages: 91
Inquire Before Buying

Transmucosal drug delivery devices are commonly used to deliver drugs locally through the mucous membrane.

Highlights

The global Transmucosal Drug Delivery Devices market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Transmucosal Drug Delivery Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Transmucosal Drug Delivery Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Transmucosal Drug Delivery Devices include Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd and Callitas Therapeutics Inc, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transmucosal Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transmucosal Drug Delivery Devices.

The Transmucosal Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Transmucosal Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Transmucosal Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Allergan

- Amphastar Pharmaceuticals Inc

- Aquestive Therapeutics Inc

- ARS Pharmaceuticals

- Combinent BioMedical Systems Inc

- Aegis Therapeutics LLC

- Bespak Europe Ltd

- Callitas Therapeutics Inc

Segment by Type

- Buccal Route

- Rectal Route

- Nasal Route

Segment by Application

- Hospital

- Residential

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Transmucosal Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Transmucosal Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Transmucosal Drug Delivery Devices Market Research Report 2023

Table of Contents
1 Transmucosal Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Transmucosal Drug Delivery Devices
1.2 Transmucosal Drug Delivery Devices Segment by Type
1.2.1 Global Transmucosal Drug Delivery Devices Market Value Comparison by Type (2023-2029)
1.2.2 Buccal Route
1.2.3 Rectal Route
1.2.4 Nasal Route
1.3 Transmucosal Drug Delivery Devices Segment by Application
1.3.1 Global Transmucosal Drug Delivery Devices Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Residential
1.4 Global Transmucosal Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Transmucosal Drug Delivery Devices Revenue 2018-2029
1.4.2 Global Transmucosal Drug Delivery Devices Sales 2018-2029
1.4.3 Global Transmucosal Drug Delivery Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Transmucosal Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Transmucosal Drug Delivery Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Transmucosal Drug Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Transmucosal Drug Delivery Devices Average Price by Manufacturers (2018-2023)
2.4 Global Transmucosal Drug Delivery Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Transmucosal Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transmucosal Drug Delivery Devices, Product Type & Application
2.7 Transmucosal Drug Delivery Devices Market Competitive Situation and Trends
2.7.1 Transmucosal Drug Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transmucosal Drug Delivery Devices Players Market Share by Revenue
2.7.3 Global Transmucosal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transmucosal Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Transmucosal Drug Delivery Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Transmucosal Drug Delivery Devices Global Transmucosal Drug Delivery Devices Sales by Region: 2018-2029
3.2.1 Global Transmucosal Drug Delivery Devices Sales by Region: 2018-2023
3.2.2 Global Transmucosal Drug Delivery Devices Sales by Region: 2024-2029
3.3 Global Transmucosal Drug Delivery Devices Global Transmucosal Drug Delivery Devices Revenue by Region: 2018-2029
3.3.1 Global Transmucosal Drug Delivery Devices Revenue by Region: 2018-2023
3.3.2 Global Transmucosal Drug Delivery Devices Revenue by Region: 2024-2029
3.4 North America Transmucosal Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Transmucosal Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Transmucosal Drug Delivery Devices Sales by Country (2018-2029)
3.4.3 North America Transmucosal Drug Delivery Devices Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transmucosal Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Transmucosal Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Transmucosal Drug Delivery Devices Sales by Country (2018-2029)
3.5.3 Europe Transmucosal Drug Delivery Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transmucosal Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Transmucosal Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Transmucosal Drug Delivery Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Transmucosal Drug Delivery Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transmucosal Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Transmucosal Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Transmucosal Drug Delivery Devices Sales by Country (2018-2029)
3.7.3 Latin America Transmucosal Drug Delivery Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transmucosal Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Transmucosal Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Transmucosal Drug Delivery Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Transmucosal Drug Delivery Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Transmucosal Drug Delivery Devices Sales by Type (2018-2029)
4.1.1 Global Transmucosal Drug Delivery Devices Sales by Type (2018-2023)
4.1.2 Global Transmucosal Drug Delivery Devices Sales by Type (2024-2029)
4.1.3 Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2018-2029)
4.2 Global Transmucosal Drug Delivery Devices Revenue by Type (2018-2029)
4.2.1 Global Transmucosal Drug Delivery Devices Revenue by Type (2018-2023)
4.2.2 Global Transmucosal Drug Delivery Devices Revenue by Type (2024-2029)
4.2.3 Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2018-2029)
4.3 Global Transmucosal Drug Delivery Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Transmucosal Drug Delivery Devices Sales by Application (2018-2029)
5.1.1 Global Transmucosal Drug Delivery Devices Sales by Application (2018-2023)
5.1.2 Global Transmucosal Drug Delivery Devices Sales by Application (2024-2029)
5.1.3 Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2018-2029)
5.2 Global Transmucosal Drug Delivery Devices Revenue by Application (2018-2029)
5.2.1 Global Transmucosal Drug Delivery Devices Revenue by Application (2018-2023)
5.2.2 Global Transmucosal Drug Delivery Devices Revenue by Application (2024-2029)
5.2.3 Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2018-2029)
5.3 Global Transmucosal Drug Delivery Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Allergan Transmucosal Drug Delivery Devices Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Amphastar Pharmaceuticals Inc
6.2.1 Amphastar Pharmaceuticals Inc Corporation Information
6.2.2 Amphastar Pharmaceuticals Inc Description and Business Overview
6.2.3 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product Portfolio
6.2.5 Amphastar Pharmaceuticals Inc Recent Developments/Updates
6.3 Aquestive Therapeutics Inc
6.3.1 Aquestive Therapeutics Inc Corporation Information
6.3.2 Aquestive Therapeutics Inc Description and Business Overview
6.3.3 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product Portfolio
6.3.5 Aquestive Therapeutics Inc Recent Developments/Updates
6.4 ARS Pharmaceuticals
6.4.1 ARS Pharmaceuticals Corporation Information
6.4.2 ARS Pharmaceuticals Description and Business Overview
6.4.3 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product Portfolio
6.4.5 ARS Pharmaceuticals Recent Developments/Updates
6.5 Combinent BioMedical Systems Inc
6.5.1 Combinent BioMedical Systems Inc Corporation Information
6.5.2 Combinent BioMedical Systems Inc Description and Business Overview
6.5.3 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product Portfolio
6.5.5 Combinent BioMedical Systems Inc Recent Developments/Updates
6.6 Aegis Therapeutics LLC
6.6.1 Aegis Therapeutics LLC Corporation Information
6.6.2 Aegis Therapeutics LLC Description and Business Overview
6.6.3 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product Portfolio
6.6.5 Aegis Therapeutics LLC Recent Developments/Updates
6.7 Bespak Europe Ltd
6.6.1 Bespak Europe Ltd Corporation Information
6.6.2 Bespak Europe Ltd Description and Business Overview
6.6.3 Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bespak Europe Ltd Transmucosal Drug Delivery Devices Product Portfolio
6.7.5 Bespak Europe Ltd Recent Developments/Updates
6.8 Callitas Therapeutics Inc
6.8.1 Callitas Therapeutics Inc Corporation Information
6.8.2 Callitas Therapeutics Inc Description and Business Overview
6.8.3 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product Portfolio
6.8.5 Callitas Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transmucosal Drug Delivery Devices Industry Chain Analysis
7.2 Transmucosal Drug Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transmucosal Drug Delivery Devices Production Mode & Process
7.4 Transmucosal Drug Delivery Devices Sales and Marketing
7.4.1 Transmucosal Drug Delivery Devices Sales Channels
7.4.2 Transmucosal Drug Delivery Devices Distributors
7.5 Transmucosal Drug Delivery Devices Customers
8 Transmucosal Drug Delivery Devices Market Dynamics
8.1 Transmucosal Drug Delivery Devices Industry Trends
8.2 Transmucosal Drug Delivery Devices Market Drivers
8.3 Transmucosal Drug Delivery Devices Market Challenges
8.4 Transmucosal Drug Delivery Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Transmucosal Drug Delivery Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Transmucosal Drug Delivery Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Transmucosal Drug Delivery Devices Market Competitive Situation by Manufacturers in 2022
Table 4. Global Transmucosal Drug Delivery Devices Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Transmucosal Drug Delivery Devices Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Transmucosal Drug Delivery Devices Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Transmucosal Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Transmucosal Drug Delivery Devices, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Transmucosal Drug Delivery Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Transmucosal Drug Delivery Devices, Product Type & Application
Table 12. Global Key Manufacturers of Transmucosal Drug Delivery Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transmucosal Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transmucosal Drug Delivery Devices as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Transmucosal Drug Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Transmucosal Drug Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 18. Global Transmucosal Drug Delivery Devices Sales Market Share by Region (2018-2023)
Table 19. Global Transmucosal Drug Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 20. Global Transmucosal Drug Delivery Devices Sales Market Share by Region (2024-2029)
Table 21. Global Transmucosal Drug Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Transmucosal Drug Delivery Devices Revenue Market Share by Region (2018-2023)
Table 23. Global Transmucosal Drug Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Transmucosal Drug Delivery Devices Revenue Market Share by Region (2024-2029)
Table 25. North America Transmucosal Drug Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Transmucosal Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 27. North America Transmucosal Drug Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 28. North America Transmucosal Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Transmucosal Drug Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Transmucosal Drug Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Transmucosal Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 32. Europe Transmucosal Drug Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 33. Europe Transmucosal Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Transmucosal Drug Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Transmucosal Drug Delivery Devices Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Transmucosal Drug Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Transmucosal Drug Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Transmucosal Drug Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Transmucosal Drug Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Transmucosal Drug Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Transmucosal Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Transmucosal Drug Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Transmucosal Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Transmucosal Drug Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Transmucosal Drug Delivery Devices Sales (K Units) by Type (2018-2023)
Table 51. Global Transmucosal Drug Delivery Devices Sales (K Units) by Type (2024-2029)
Table 52. Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2018-2023)
Table 53. Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2024-2029)
Table 54. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2018-2023)
Table 57. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2024-2029)
Table 58. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Type (2018-2023)
Table 59. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Type (2024-2029)
Table 60. Global Transmucosal Drug Delivery Devices Sales (K Units) by Application (2018-2023)
Table 61. Global Transmucosal Drug Delivery Devices Sales (K Units) by Application (2024-2029)
Table 62. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2018-2023)
Table 63. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2024-2029)
Table 64. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2018-2023)
Table 67. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2024-2029)
Table 68. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Application (2018-2023)
Table 69. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Application (2024-2029)
Table 70. Allergan Corporation Information
Table 71. Allergan Description and Business Overview
Table 72. Allergan Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Allergan Transmucosal Drug Delivery Devices Product
Table 74. Allergan Recent Developments/Updates
Table 75. Amphastar Pharmaceuticals Inc Corporation Information
Table 76. Amphastar Pharmaceuticals Inc Description and Business Overview
Table 77. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product
Table 79. Amphastar Pharmaceuticals Inc Recent Developments/Updates
Table 80. Aquestive Therapeutics Inc Corporation Information
Table 81. Aquestive Therapeutics Inc Description and Business Overview
Table 82. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product
Table 84. Aquestive Therapeutics Inc Recent Developments/Updates
Table 85. ARS Pharmaceuticals Corporation Information
Table 86. ARS Pharmaceuticals Description and Business Overview
Table 87. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product
Table 89. ARS Pharmaceuticals Recent Developments/Updates
Table 90. Combinent BioMedical Systems Inc Corporation Information
Table 91. Combinent BioMedical Systems Inc Description and Business Overview
Table 92. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product
Table 94. Combinent BioMedical Systems Inc Recent Developments/Updates
Table 95. Aegis Therapeutics LLC Corporation Information
Table 96. Aegis Therapeutics LLC Description and Business Overview
Table 97. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product
Table 99. Aegis Therapeutics LLC Recent Developments/Updates
Table 100. Bespak Europe Ltd Corporation Information
Table 101. Bespak Europe Ltd Description and Business Overview
Table 102. Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Bespak Europe Ltd Transmucosal Drug Delivery Devices Product
Table 104. Bespak Europe Ltd Recent Developments/Updates
Table 105. Callitas Therapeutics Inc Corporation Information
Table 106. Callitas Therapeutics Inc Description and Business Overview
Table 107. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product
Table 109. Callitas Therapeutics Inc Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Transmucosal Drug Delivery Devices Distributors List
Table 113. Transmucosal Drug Delivery Devices Customers List
Table 114. Transmucosal Drug Delivery Devices Market Trends
Table 115. Transmucosal Drug Delivery Devices Market Drivers
Table 116. Transmucosal Drug Delivery Devices Market Challenges
Table 117. Transmucosal Drug Delivery Devices Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Transmucosal Drug Delivery Devices
Figure 2. Global Transmucosal Drug Delivery Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Transmucosal Drug Delivery Devices Market Share by Type in 2022 & 2029
Figure 4. Buccal Route Product Picture
Figure 5. Rectal Route Product Picture
Figure 6. Nasal Route Product Picture
Figure 7. Global Transmucosal Drug Delivery Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Transmucosal Drug Delivery Devices Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Residential
Figure 11. Global Transmucosal Drug Delivery Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Transmucosal Drug Delivery Devices Market Size (2018-2029) & (US$ Million)
Figure 13. Global Transmucosal Drug Delivery Devices Sales (2018-2029) & (K Units)
Figure 14. Global Transmucosal Drug Delivery Devices Average Price (USD/Unit) & (2018-2029)
Figure 15. Transmucosal Drug Delivery Devices Report Years Considered
Figure 16. Transmucosal Drug Delivery Devices Sales Share by Manufacturers in 2022
Figure 17. Global Transmucosal Drug Delivery Devices Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Transmucosal Drug Delivery Devices Players: Market Share by Revenue in 2022
Figure 19. Transmucosal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Transmucosal Drug Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Transmucosal Drug Delivery Devices Sales Market Share by Country (2018-2029)
Figure 22. North America Transmucosal Drug Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Transmucosal Drug Delivery Devices Sales Market Share by Country (2018-2029)
Figure 26. Europe Transmucosal Drug Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 27. Germany Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Transmucosal Drug Delivery Devices Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Transmucosal Drug Delivery Devices Revenue Market Share by Region (2018-2029)
Figure 34. China Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Transmucosal Drug Delivery Devices Sales Market Share by Country (2018-2029)
Figure 45. Latin America Transmucosal Drug Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Transmucosal Drug Delivery Devices Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Transmucosal Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Transmucosal Drug Delivery Devices by Type (2018-2029)
Figure 55. Global Revenue Market Share of Transmucosal Drug Delivery Devices by Type (2018-2029)
Figure 56. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Transmucosal Drug Delivery Devices by Application (2018-2029)
Figure 58. Global Revenue Market Share of Transmucosal Drug Delivery Devices by Application (2018-2029)
Figure 59. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Application (2018-2029)
Figure 60. Transmucosal Drug Delivery Devices Value Chain
Figure 61. Transmucosal Drug Delivery Devices Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs